Clinical Trials Logo

Clinical Trial Summary

The main objective for this study is validation for the proposed risk stratification tool, by evaluating the clinical outcomes for its use post TKR Surgeries. For this objective, the design that is used is Randomized Trial.


Clinical Trial Description

All patients that will have total knee replacement, in a given period of time in both medical centers; Prince Sultan Military Medical City (PSMMC) and King Abd Allah University Hospital (KAAUH) in Princess Noura University, will be randomly separated into 2 groups; in the first group (A): Venous thromboembolism (VTE) risk stratification tool (which is prepared by a clinical pharmacist) will be applied to choose the tailored extended VTE prophylactic agent. While in the second group (B), the risk stratification tool will not be used, rather it will follow the routine hospital protocol for choosing the VTE prophylactic agent, which is Caprini: a standard validated model. Then each group of patients will be followed till 35 days postā€operation, during which all VTE or bleeding events should be recorded. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04031859
Study type Interventional
Source Ministry of Health, Saudi Arabia
Contact
Status Completed
Phase Phase 2
Start date October 10, 2018
Completion date July 22, 2019